Importance Given the role of inflammation in cancer progression, neutrophil-lymphocyte
ratio (NLR) from peripheral blood has been suggested as a readout of systemic
inflammation and a prognostic marker in several solid malignant neoplasms. However,
optimal threshold for NLR in US patients with head and neck cancer remains unclear.
Objective To evaluate the optimal NLR threshold as a potential prognostic biomarker for
survival outcomes. Design, Setting, and Participants This retrospective cohort study was …